1-Phenoxyalkyl-4-[(N,N-disubstitutedamino)alkyl]piperazine derivatives as non-imidazole histamine H3-antagonists

Medicinal Chemistry Research

Volumn 22, Issue 3, 2013, Pages 1287-1304

  Staszewski, Marek ^a   Walczyński, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

1 Phenoxyalkyl 4 (N,N disubstitutedamino)alkyl piperazine derivatives; H3 antagonists; Histamine H3 receptor

Indexed keywords

HISTAMINE H3 RECEPTOR ANTAGONIST; MEPYRAMINE; PIPERAZINE DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; IN VITRO STUDY; NONHUMAN; THIN LAYER CHROMATOGRAPHY;

EID: 84874105257     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0090-2     Document Type: Article

References (45)

1. 3 receptor in rat cerebral cortex. Br J Pharmacol 118:2045-2052
2. 3 receptor antagonists: 4-(aminoalkoxy)benzylamines. J Med Chem 46:3938-3944
3. 3) of histamine receptor. Nature 302:832-837
4. 3-receptors. Neuroscience 15:553-562
5. 3-receptors. Neuroscience 23:149-157
6. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58
7. Banik BK, Becker FF (2001) Polycyclic aromatic compounds as anticancer agents: structure-activity relationships of chrysene and pyrene derivatives. Bioorg Med Chem 9:593-605
8. Berlin M, Boyce CW, de Lera Ruiz M (2011) Histamine H3 receptor as a drug discovery target. J Med Chem 54:26-53
9. Capuano B, Crosby IT, Lloyd EJ, Podloucka A, Taylor DA (2008) Synthesis and preliminary pharmacological evaluation of 4'-Arylalkyl analogues of Clozapine. IV. The effects of the aromatic and isosteric replacement. Aust J Chem 61:930-940
10. Clapham J, Kilpatrick GJ (1992) Histamine H3-receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3-receptor subtypes. J Pharmacol 107:919-923
11. Collins RF, Davis M (1961) The chemotherapy of schistosomiasis. Part IV. Some ethers of 4-amino-2-methoxyphenol. J Chem Soc (May):1863-1879
12. 3 receptor antagonists potently enhance cognition and attention. J Med Chem 48:38-55
13. 3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n- propylpiperazine derivatives. Eur J Med Chem 44:1674-1681
14. Glase SA, Robertson DW, Wise LD (2002) Attention deficit hyperactivity disorder: Pathophysiology and design of new treatments. Annu Rep Med Chem 37:11-20
15. 3-receptor antagonists. Arch Pharm Med Chem 328:445-450
16. Labella FS, Queen G, Glavin G, Durant G, Stein D, Brandes IJ (1992) H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. Br J Pharmacol 107:161-164
17. Lehman MR, Thompson CD, Marvel CS (1933) Quaternary ammonium salts from halogenated alkyl dimethylamines. III. omega-bromo-heptyl-, -octyl-, -nonyl- and -decyl-dimethylamines. J Am Chem Soc 55:1977-1981
18. Leurs R, Tulup MT, Menge WM, Adolfs MJ, Zuiderveld OP, Timmerman H (1995) Evaluation of receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br J Pharmacol 116:2315-2321
19. 3 receptor agonists and antagonists. Trends Pharmacol Sci 19:177-183
20. 3 receptor drugs. Nat Rev Drug Discov 4:107-120
21. 3-receptor antagonist. J Pharmacol Exp Therap 287:658-666
22. 3 receptors: role of two amino acids in the third transmembrane domain. Br J Pharmacol 131:1247-1250
23. Littmann ER, Marvel CS (1930) Cyclic quaternary ammonium salts from halogenated aliphatic tertiary amines. J Am Chem Soc 52:287-294
24. 4) expressed in bone marrow. Mol Pharmacol 59:420-426
25. 3 receptor. Mol Pharmacol 55:1101-1107
26. 3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Therap 293:771-778
27. 3-receptor antagonists. Eur J Pharm Sci 13:249-259
28. 3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds. J Med Chem 46:1523-1530
29. 3 receptor antagonists. Bioorg Med Chem 12:2727-2736
30. 3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmideberg's Arch Pharmacol 337:588-590
31. 3 receptors. Naunyn-Schmideberg's Arch Pharmacol 340:633-638
32. 3 heteroreceptors. Fundam Clin Pharmacol 8:128-137
33. 3 receptors. Bioorg Med Chem Lett 11:951-954
34. Tkaczyński T (1966) Synthesis of ethylene amines N-hydroxyethylpiperazine and N,N-bis-hydroxyethylpiperazine. Acta Pol Pharm 4:355-357
35. 3-receptor. Eur J Med Chem 27:511-517
36. Van Es A, Stevens W (1965) Mixed carboxylic acid anhydrides: V. Synthesis of alkyl formates. Recl Trav Chim Pays-Bas 84:704-709
37. 3-receptor ligands: a possible role in the mechanism and management of epilepsy. Pharmacol Biochem Behav 68:735-741
38. Vollinga RC, Zuiderveld OP, Scheerens H, Bast A, Timmerman H (1992) A simple and rapid in system for the screening of histamine H3-ligands. Methods Find Exp Clin Pharmacol 105:747-751
39. 1 blocking activities. Il Farmaco 54:684-694
40. 3 antagonists. Arch Pharm Pharm Med Chem 332:389-398
41. 3-antagonists. Eur J Med 40:15-23
42. 3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system. Pharmacol Ther 103:1-20
43. 3 receptors. Eur J Pharmacol 453:33-41
44. Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M, Sakata T (1999) Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes 48:2286-2291
45. 3 receptor antagonists. J Med Chem 48:306-311